Stock listing

NASDAQ:XLRN Acceleron Pharma Inc Stock

Follow Acceleron Pharma Inc into a list and get an email when it puts out news.

Last close · NASDAQ:XLRN

$178.75 USD

Close on Nov 22, 2021 · No longer trades

Sep 19, 2013 to last close +794.2% · weekly closes, Sep 19, 2013 – Nov 22, 2021
Lowest – highest close
$17.40 – $182.78 USDSince Sep 19, 2013 · lowest Nov 7, 2013 · highest Sep 28, 2021

Delisted NASDAQ:XLRN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:XLRN
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Acceleron Pharma Inc on 6ix

Decks
13 decks · latest Jun 22, 2021

Decks

DeckKindSlidesDate
Investor Day (June 2021)Investor day139 slidesJun 22, 2021
ATS 2021 International ConferenceConference40 slidesMay 19, 2021
J.P. Morgan 39th Annual Healthcare Conference (January 2021)Conference23 slidesJan 11, 2021
AHA Scientific Sessions 2020 VirtualConference42 slidesNov 13, 2020
Technical Presentation (October 2020)Technical31 slidesOct 2, 2020
Investor Presentation (January 2019)Investor deck39 slidesJan 7, 2019
ASH 2018 MEDALIST & BELIEVE Phase 3 Trial Presentation callConference41 slidesDec 3, 2018
Technical Presentation (December 2018)Technical18 slidesDec 3, 2018
60th Annual Meeting of the American Society of Hematology (ASH) 2018Conference17 slidesDec 3, 2018
JP Morgan Healthcare Conference 2018Conference29 slidesJan 8, 2018
All 13 decks
DeckKindSlidesDate
35th Annual J.P. Morgan Healthcare Conference 2017Conference23 slidesJan 9, 2017
Investor Day (October 2015)Investor day92 slidesOct 23, 2015
Investor Presentation (January 2015)Investor deck68 slidesJan 12, 2015

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Karen Smith
Other companies: Context Therapeutics Inc. (Independent Director · Since at least Sep 4, 2024); Skye Bioscience, Inc. (Director · Since at least Jul 2, 2024); Sangamo Therapeutics, Inc. (Director · Since at least Jun 26, 2018); Aurinia Pharmaceuticals Inc (Director · Aug 18, 2023 – Nov 21, 2024 · Past); Quince Therapeutics, Inc. (Chief Medical Officer · May 19, 2022 – Feb 1, 2023 · Past); Tourmaline Bio Inc. (Director · May 16, 2022 – Jun 13, 2023 · Past); Emergent BioSolutions Inc. (EVP, Chief Medical Officer · May 21, 2020 – May 7, 2021 · Past); Antares Pharma Inc (Director · Mar 1, 2019 – May 24, 2022 · Past); Sucampo Pharmaceuticals Inc (Director · Jul 15, 2017 – Feb 13, 2018 · Past); Jazz Pharmaceuticals plc (EVP, R&D and CMO · Apr 13, 2015 – Mar 5, 2018 · Past)
Director · Nov 15, 2017 – Nov 19, 2021 · Past
Terrance McGuire
Other companies: Tectonic Therapeutic, Inc. (Director · Since at least Jun 20, 2024); Invivyd, Inc. (Director · Since at least Aug 5, 2021); Seer, Inc. (Director · Since at least Dec 3, 2020); Cyclerion Therapeutics, Inc. (Director · Apr 1, 2019 – Nov 30, 2023 · Past); Alector, Inc. (Director · Feb 6, 2019 – Sep 11, 2023 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Pulmatrix, Inc. (Director · Jun 15, 2015 – May 16, 2019 · Past); Trevena, Inc. (Director · Jan 30, 2014 – May 14, 2014 · Past); Ironwood Pharmaceuticals, Inc. (Director · Jun 3, 2013 – Apr 1, 2019 · Past)
Director · Sep 18, 2013 – Mar 2, 2017 · Past
François Nader
Other companies: Tectonic Therapeutic, Inc. (Chair, Board of Directors · Since at least Feb 23, 2026); Moderna, Inc. (Director · Since at least Dec 10, 2019); Tourmaline Bio Inc. (Director · May 6, 2021 – Jun 13, 2023 · Past); Prevail Therapeutics Inc (Director · Jun 19, 2019 – Jan 22, 2021 · Past); Alexion Pharmaceuticals Inc (Director · Nov 15, 2017 – Jul 21, 2021 · Past); Baxalta Inc (Director · Jul 27, 2015 – Jun 3, 2016 · Past); Trevena, Inc. (Director · Jan 30, 2014 – May 20, 2015 · Past); NPS Pharmaceuticals Inc (President, CEO and Director, Director · Apr 8, 2013 – Feb 21, 2015 · Past)
Director · Dec 11, 2014 – Nov 19, 2021 · Past
Habib Joseph Dable
Other companies: Tyra Biosciences, Inc. (Director · Since at least Apr 16, 2026); SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Relay Therapeutics, Inc. (Director · Since at least Nov 4, 2025); Day One Biopharmaceuticals Inc (Director · Since at least Jan 17, 2024); PepGen Inc. (Director · Since at least Sep 20, 2022); Blueprint Medicines Corp (Director · Since at least Jun 23, 2022); Jade Biosciences, Inc. (Director · Jul 10, 2023 – Jun 5, 2024 · Past); Albireo Pharma Inc (Director · Aug 8, 2022 – Mar 2, 2023 · Past)
CEO and President, Director · Jan 4, 2021 – Nov 19, 2021 · Past
Jean George
Other companies: Cyteir Therapeutics Inc (Director · Jun 17, 2021 – Feb 14, 2024 · Past); Disc Medicine, Inc. (Director · Feb 5, 2021 – Feb 5, 2021 · Past); Astria Therapeutics Inc (Director · Jun 24, 2015 – Jun 7, 2018 · Past); Calithera Biosciences, Inc. (Director · Oct 1, 2014 – Jun 11, 2021 · Past); Portola Pharmaceuticals Inc (Director · May 21, 2013 – May 28, 2013 · Past); Zeltiq Aesthetics Inc (Director · Oct 18, 2011 – Jul 22, 2015 · Past)
Director · Sep 18, 2013 – Jan 22, 2020 · Past
Kevin F. McLaughlin
Other companies: Invivyd, Inc. (Director · Since at least May 21, 2024); Vericel Corporation (Director · Since at least Jan 6, 2015); Decibel Therapeutics Inc (Director · Oct 10, 2022 – Sep 25, 2023 · Past)
SVP, CFO and Treasurer · Jul 7, 2015 – Nov 19, 2021 · Past
Richard F. Pops
Other companies: Alkermes plc (Director · Since at least Sep 10, 2015); Neurocrine Biosciences, Inc. (Director · Since at least May 28, 2015); Epizyme Inc (Director · Jul 8, 2015 – May 29, 2020 · Past)
Director · Mar 3, 2016 – Jan 25, 2019 · Past
Adam Veness
Other companies: Dianthus Therapeutics, Inc. (General Counsel · Since at least Sep 11, 2023); Cyteir Therapeutics Inc (General Counsel · Apr 25, 2022 – Feb 3, 2023 · Past)
SVP, General Counsel and Sec. · Jan 4, 2021 – Nov 19, 2021 · Past
John Quisel
Other companies: Gossamer Bio, Inc. (Director · Since at least Nov 28, 2023); Disc Medicine, Inc. (Chief Executive Officer · Since at least Dec 29, 2022)
EVP, Chief Business Officer · Sep 18, 2013 – Jan 2, 2020 · Past
Robert K Zeldin
Other companies: MeiraGTx Holdings plc (CHIEF MEDICAL OFFICER · Since at least Aug 3, 2020); Immunovant, Inc. (Chief Medical Officer · Dec 18, 2019 – Dec 18, 2019 · Past)
EVP & Chief Medical Officer · Jun 29, 2018 – Jan 25, 2019 · Past
All 13 people
PersonSeat
Sujay Kango
Other companies: Dianthus Therapeutics, Inc. (Director · Since at least Mar 4, 2025); Lite Strategy, Inc. (Director · Nov 22, 2021 – Sep 29, 2023 · Past)
EVP, Chief Commercial Officer · Feb 12, 2018 – Nov 19, 2021 · Past
Kemal Malik
Other companies: Cartesian Therapeutics, Inc. (Director · Since at least Jul 1, 2024)
Director · Jan 2, 2020 – Nov 19, 2021 · Past
Ravindra KumarSVP & Chief Scientific Officer · Oct 6, 2016 – Sep 10, 2019 · Past

Open People

Log in to ask 6ix AI your own questions about Acceleron Pharma Inc.